240 related articles for article (PubMed ID: 16027051)
21. Designer drug 2,4,5-trimethoxyamphetamine (TMA-2): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques.
Ewald AH; Fritschi G; Maurer HH
J Mass Spectrom; 2006 Sep; 41(9):1140-8. PubMed ID: 16810708
[TBL] [Abstract][Full Text] [Related]
22. Determination of amphetamine-derived designer drugs in human urine by SPE extraction and capillary electrophoresis with mass spectrometry detection.
Boatto G; Nieddu M; Carta A; Pau A; Palomba M; Asproni B; Cerri R
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jan; 814(1):93-8. PubMed ID: 15607712
[TBL] [Abstract][Full Text] [Related]
23. Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry.
Meyer MR; Wilhelm J; Peters FT; Maurer HH
Anal Bioanal Chem; 2010 Jun; 397(3):1225-33. PubMed ID: 20333362
[TBL] [Abstract][Full Text] [Related]
24. Preventive doping control analysis: liquid and gas chromatography time-of-flight mass spectrometry for detection of designer steroids.
Georgakopoulos CG; Vonaparti A; Stamou M; Kiousi P; Lyris E; Angelis YS; Tsoupras G; Wuest B; Nielen MW; Panderi I; Koupparis M
Rapid Commun Mass Spectrom; 2007; 21(15):2439-46. PubMed ID: 17610244
[TBL] [Abstract][Full Text] [Related]
25. The in vivo and in vitro metabolism and the detectability in urine of 3',4'-methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP), a new pyrrolidinophenone-type designer drug, studied by GC-MS and LC-MS(n.).
Meyer MR; Mauer S; Meyer GM; Dinger J; Klein B; Westphal F; Maurer HH
Drug Test Anal; 2014; 6(7-8):746-56. PubMed ID: 24124065
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous determination of amphetamine derivatives in human urine after SPE extraction and HPLC-UV analysis.
Soares ME; Carvalho M; Carmo H; Remião F; Carvalho F; Bastos ML
Biomed Chromatogr; 2004 Mar; 18(2):125-31. PubMed ID: 15039965
[TBL] [Abstract][Full Text] [Related]
27. Urine testing for designer steroids by liquid chromatography with androgen bioassay detection and electrospray quadrupole time-of-flight mass spectrometry identification.
Nielen MW; Bovee TF; van Engelen MC; Rutgers P; Hamers AR; van Rhijn JH; Hoogenboom LR
Anal Chem; 2006 Jan; 78(2):424-31. PubMed ID: 16408923
[TBL] [Abstract][Full Text] [Related]
28. Lefetamine-derived designer drugs N-ethyl-1,2-diphenylethylamine (NEDPA) and N-iso-propyl-1,2-diphenylethylamine (NPDPA): metabolism and detectability in rat urine using GC-MS, LC-MSn and LC-HR-MS/MS.
Wink CS; Meyer GM; Wissenbach DK; Jacobsen-Bauer A; Meyer MR; Maurer HH
Drug Test Anal; 2014 Oct; 6(10):1038-48. PubMed ID: 24591097
[TBL] [Abstract][Full Text] [Related]
29. Toxicological detection of the new designer drug 1-(4-methoxyphenyl)piperazine and its metabolites in urine and differentiation from an intake of structurally related medicaments using gas chromatography-mass spectrometry.
Staack RF; Maurer HH
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Dec; 798(2):333-42. PubMed ID: 14643514
[TBL] [Abstract][Full Text] [Related]
30. A systematic comparison of four different workup procedures for systematic toxicological analysis of urine samples using gas chromatography-mass spectrometry.
Peters FT; Drvarov O; Lottner S; Spellmeier A; Rieger K; Haefeli WE; Maurer HH
Anal Bioanal Chem; 2009 Jan; 393(2):735-45. PubMed ID: 18974980
[TBL] [Abstract][Full Text] [Related]
31. LC-MS analysis of trimethoxyamphetamine designer drugs (TMA series) from urine samples.
Nieddu M; Boatto G; Pirisi MA; Azara E; Marchetti M
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 May; 867(1):126-30. PubMed ID: 18417429
[TBL] [Abstract][Full Text] [Related]
32. Studies on the metabolism of the Delta9-tetrahydrocannabinol precursor Delta9-tetrahydrocannabinolic acid A (Delta9-THCA-A) in rat using LC-MS/MS, LC-QTOF MS and GC-MS techniques.
Jung J; Meyer MR; Maurer HH; Neusüss C; Weinmann W; Auwärter V
J Mass Spectrom; 2009 Oct; 44(10):1423-33. PubMed ID: 19728318
[TBL] [Abstract][Full Text] [Related]
33. Low resolution and high resolution MS for studies on the metabolism and toxicological detection of the new psychoactive substance methoxypiperamide (MeOP).
Meyer MR; Holderbaum A; Kavanagh P; Maurer HH
J Mass Spectrom; 2015 Oct; 50(10):1163-74. PubMed ID: 26456786
[TBL] [Abstract][Full Text] [Related]
34. Solvent-enhanced microwave-assisted derivatization following solid-phase extraction combined with gas chromatography-mass spectrometry for determination of amphetamines in urine.
Chung LW; Liu GJ; Li ZG; Chang YZ; Lee MR
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Oct; 874(1-2):115-8. PubMed ID: 18815079
[TBL] [Abstract][Full Text] [Related]
35. Screening for and validated quantification of phenethylamine-type designer drugs and mescaline in human blood plasma by gas chromatography/mass spectrometry.
Habrdova V; Peters FT; Theobald DS; Maurer HH
J Mass Spectrom; 2005 Jun; 40(6):785-95. PubMed ID: 15827969
[TBL] [Abstract][Full Text] [Related]
36. Metabolism of the new designer drug alpha-pyrrolidinopropiophenone (PPP) and the toxicological detection of PPP and 4'-methyl-alpha-pyrrolidinopropiophenone (MPPP) studied in rat urine using gas chromatography-mass spectrometry.
Springer D; Fritschi G; Maurer HH
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Nov; 796(2):253-66. PubMed ID: 14581066
[TBL] [Abstract][Full Text] [Related]
37. [The analysis of the methylenedioxy derivatives of amphetamine].
Veselovskaia NV; Simonov EA; Sorokin VI; Drozdov MA; Izotov BN; Andriiako TB; Dorogokupets OB; Morozova EB; Kovalenko AE
Sud Med Ekspert; 1999; 42(3):23-30. PubMed ID: 10396963
[TBL] [Abstract][Full Text] [Related]
38. On the metabolism of the amphetamine-derived antispasmodic drug mebeverine: gas chromatography-mass spectrometry studies on rat liver microsomes and on human urine.
Kraemer T; Bickeboeller-Friedrich J; Maurer HH
Drug Metab Dispos; 2000 Mar; 28(3):339-47. PubMed ID: 10681380
[TBL] [Abstract][Full Text] [Related]
39. Integration of GC/EI-MS and GC/NCI-MS for simultaneous quantitative determination of opiates, amphetamines, MDMA, ketamine, and metabolites in human hair.
Wu YH; Lin KL; Chen SC; Chang YZ
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):192-202. PubMed ID: 18585989
[TBL] [Abstract][Full Text] [Related]
40. Studies on the metabolism and toxicological detection of the new designer drug N-benzylpiperazine in urine using gas chromatography-mass spectrometry.
Staack RF; Fritschi G; Maurer HH
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jun; 773(1):35-46. PubMed ID: 12015268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
